NCT05835843Completed
Study to Assess the Reliability of PASI Scoring Using Digital-Based Images
Study to Assess the Reliability of Psoriasis Area Severity Index Scoring Using Digital-Based Images Compared to In-Person Evaluation
Source: ClinicalTrials.gov · Last updated 12 Sept 2025
Brief summary (registry, in English)
This is an open-labeled study to evaluate the reliability of digital photographs for the remote assessment of the disease severity of plaque psoriasis.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 34 (actual)
- First submitted
- 18 Apr 2023
- Start date
- 2 Jun 2023
- Primary completion date
- 9 Jul 2024
- Lead sponsor
- Innovaderm Research Inc.
- Diseases
- Psoriasis
- NCT number
- NCT05835843
What you commit to
- Study type: Observational
- Participants enrolled: 34
- From 2 Jun 2023 to the primary completion date, 9 Jul 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- 1\. Subject has a history of skin disease or presence of skin condition that, in the opinion of the investigator, would interfere with the study assessments.
Who the study is looking for
- Male and female subjects aged 18 to 75 years, inclusive, at the time of consent.
- Subject has at least a 6-month history of plaque psoriasis prior to screening visit (information obtained from medical chart or subject's physician, or directly from the subject).
- Subject has plaque psoriasis covering at least 0.5% his/her total BSA at screening/Day 1 visit.
- Subject has a PGA score ≥2 at screening/Day 1 visit.
Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Innovaderm Research Coordinator of this site? Confirm its status | Montreal | Canada | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.